01/15
Headlines

NYSE:HAL

Whats Hot Today : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Halliburton Company (NYSE:HAL), MWI Veterinary Supply, Inc. (NASDAQ:MWIV), K12, Inc. (NYSE:LRN), General Motors (NYSE:GM)

Jayne Crisman02 mins

On Oct 15, ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it will report its third quarter 2014 financial results on Wednesday, November 5, 2014, before the market opens. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is 6.53%. On last trading day company shares ended up $5.71. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from…

Read More

Traders Are Watching: Halliburton Company (NYSE:HAL), Lloyds Banking Group plc (NYSE:LYG), Vodafone Group Plc (ADR) (NASDAQ:VOD), Foresight Energy LP (NYSE:FELP), PrivateBancorp (NASDAQ:PVTB)

Chris Lewis02 mins

Halliburton Company (NYSE:HAL) has earned a consensus rating of “Buy” from the thirty analysts that are covering the company, Stock Ratings News reports. Five research analysts have rated the stock with a hold rating, twenty-two have given a buy rating and one has given a strong buy rating to the company. Halliburton Company (NYSE:HAL) belongs…

Read More

Top Wall Street Stories : Brooks Automation (NASDAQ:BRKS), Fidelity National Information (NYSE:FIS), Halliburton (NYSE:HAL), Abercrombie & Fitch Co. (NYSE:ANF), Adobe (NASDAQ:ADBE)

Mark DeFrance03 mins

Brooks Automation Inc. (NASDAQ:BRKS) Insider David Pietrantoni unloaded 2,500 shares of the company’s stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $11.07, for a total transaction of $27,675.00. Following the transaction, the insider now directly owns 78,486 shares of the company’s stock, valued at…

Read More

Investors Are Watching : Halliburton Company (NYSE:HAL), Insmed (NASDAQ:INSM), FactSet Research Systems (NYSE:FDS), Keurig Green Mountain, Inc. (NASDAQ:GMCR), Great Panther (NYSEMKT:GPL)

Colin Pettis03 mins

Halliburton Company (NYSE:HAL)‘s stock had its “neutral” rating reaffirmed by Zacks in a note issued to investors on Friday. They currently have a $71.00 target price on the stock. Zacks‘s target price indicates a potential upside of 5.01% from the stock’s previous close. Halliburton Company (NYSE:HAL) belongs to Basic Materials sector. Its net profit margin…

Read More

Don’t Miss: Merrimack Pharmaceuticals (NASDAQ:MACK), Acorda Therapeutics (NASDAQ:ACOR), USA Compression Partners, LP (NYSE:USAC), Halliburton Company (NYSE:HAL), Google Inc. (NASDAQ:GOOG)

Kevin Long03 mins

On 4 AUG Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that the company will host its Second Quarter 2014 Investor Conference Call on Monday, August 11. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) belongs to Healthcare sector. Its weekly performance is 12.98%. On last trading day company shares ended up $6.53. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) distance from 50-day simple moving…

Read More

Watch List: Halliburton Company (NYSE:HAL), Mead Johnson Nutrition CO (NYSE:MJN), Allison Transmission Holdings Inc (NYSE:ALSN), The Gap Inc. (NYSE:GPS), Solazyme Inc (NASDAQ:SZYM)

Mark Doerr03 mins

Halliburton Company (NYSE:HAL) CEO David J. Lesar sold 35,350 shares of Halliburton Company stock on the open market in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $67.99, for a total value of $2,403,446.50. Following the transaction, the chief executive officer now directly owns 576,372 shares…

Read More